-+ 0.00%
-+ 0.00%
-+ 0.00%

DOGWOOD THERAPEUTICS INC - Q1 2026 NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS WAS $5.0 MLN OR $0.15 PER SHARE

Reuters·05/14/2026 12:30:01

Please log in to view news